Healthcare & Medical Devices Global On demand · 24-48h

Global Blood Gas Biochemistry Analyzer Market Strategic Research Report

Global Blood Gas Biochemistry Analyzer Market Strategic Rese…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Blood Gas Biochemistry Analyzer Market
$4.26B2025
5.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Desktop Type, Mobile Type

By Application: Hospital & Critical Care Settings, Other Healthcare Settings, Non-Hospital Applications

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Roche, Abbott, Werfen, Siemens, Danaher (Radiometer), Edan Instruments, Seamaty, Wondfo (Wondko), i-sens, Perlong Medical, Wuhan EasyDiagnosis, Beckman Coulter, Sysmex, HORIBA, IDEXX Laboratories, Eaglenos, OPTIMedical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 130 pages
Market size 2025
$4.26B
Billion USD
Forecast CAGR
5.5%
2025-2032
Forecast 2032
$6.2B
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Blood Gas Biochemistry Analyzer market size is predicted to grow from US$ 4,262 million in 2025 to US$ 6,183 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.

Blood Gas Biochemistry Analyzer refers to medical devices used to perform blood gas analysis (BGA). This is a diagnostic test that measures the levels of dissolved gases—primarily oxygen (O₂) and carbon dioxide (CO₂)—and the acid-base balance (pH) in a patient's blood, typically from an arterial sample.

Market Drivers

Rising Prevalence of Critical & Chronic Diseases: The increasing global burden of conditions that impair respiratory function—such as Chronic Obstructive Pulmonary Disease (COPD), asthma, diabetic ketoacidosis, and sepsis—creates sustained demand for rapid diagnostic tools.

Expansion of Point-of-Care Testing (POCT): There is a strong clinical shift toward decentralized testing. POC blood gas analyzers deliver results in minutes at the patient's bedside, enabling faster clinical decision-making, which improves outcomes in emergency rooms, ICUs, and operating theaters.

Aging Global Population: Older adults are more susceptible to respiratory and metabolic disorders, as well as undergoing more surgical procedures, directly driving the need for blood gas monitoring.

Technological Advancements: Innovations such as miniaturized cartridges, enhanced connectivity (IoT/HL7 integration), improved data management software, and multi-parameter testing (combining blood gases with electrolytes, lactate, and CO-oximetry) are making devices more versatile, user-friendly, and data-rich, encouraging adoption and upgrades.

This report presents a comprehensive overview of the global Blood Gas Biochemistry Analyzer market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Desktop Type
  • Mobile Type

Segment by Target User

  • Medical
  • Veterinary

Segment by Marketing Method

  • Direct Sales
  • Distribution

Segment by Application

  • Hospital & Critical Care Settings
  • Other Healthcare Settings
  • Non-Hospital Applications

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Blood Gas Biochemistry Analyzer market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital & Critical Care Settings, Other Healthcare Settings, Non-Hospital Applications evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Blood Gas Biochemistry Analyzer Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$4.26B
2025
Forecast
$6.2B
2032
CAGR
5.5%
2025–2032
リージョン
5
global
Key companies
RocheAbbottWerfenSiemensDanaher (Radiometer)Edan InstrumentsSeamatyWondfo (Wondko)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Desktop TypeMobile Type
By Application
Hospital & Critical Care SettingsOther Healthcare SettingsNon-Hospital Applications

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Desktop Type
  • 3.1.3 Mobile Type
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital & Critical Care Settings
  • 4.1.3 Other Healthcare Settings
  • 4.1.4 Non-Hospital Applications
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Roche
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Abbott
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Werfen
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Siemens
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Danaher (Radiometer)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Edan Instruments
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Seamaty
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Wondfo (Wondko)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 i-sens
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Perlong Medical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Wuhan EasyDiagnosis
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Beckman Coulter
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Sysmex
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 HORIBA
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 IDEXX Laboratories
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Eaglenos
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 OPTIMedical
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Blood Gas Biochemistry Analyzer market?
The global Blood Gas Biochemistry Analyzer market is estimated at US$ 4.26 billion in 2025 (base year) and is projected to reach US$ 6.18 billion by 2032.
How fast is the Blood Gas Biochemistry Analyzer market expected to grow?
The market is expected to grow at a CAGR of 5.5% from 2026 to 2032, expanding from US$ 4.26 billion in 2025 to US$ 6.18 billion in 2032, roughly 1.5 times its base-year value.
What does the Blood Gas Biochemistry Analyzer market cover?
Blood Gas Biochemistry Analyzer refers to medical devices used to perform blood gas analysis (BGA). This is a diagnostic test that measures the levels of dissolved gases—primarily oxygen (O₂) and carbon dioxide (CO₂)—and the acid-base balance (pH) in a patient's blood, typically from an arterial sample.
How is the Blood Gas Biochemistry Analyzer market segmented by type?
By type, the market is segmented into Desktop Type and Mobile Type.
What are the key applications of Blood Gas Biochemistry Analyzer?
Key applications covered include Hospital & Critical Care Settings, Other Healthcare Settings and Non-Hospital Applications.
Which companies are profiled in the Blood Gas Biochemistry Analyzer market report?
Key players profiled include Roche, Abbott, Werfen, Siemens, Danaher (Radiometer), Edan Instruments, Seamaty and Wondfo (Wondko), among 17 companies covered in total.
What geographies does the Blood Gas Biochemistry Analyzer market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Blood Gas Biochemistry Analyzer?
Aging Global Population: Older adults are more susceptible to respiratory and metabolic disorders, as well as undergoing more surgical procedures, directly driving the need for blood gas monitoring.
Who should buy the Blood Gas Biochemistry Analyzer market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital & Critical Care Settings, Other Healthcare Settings and Non-Hospital Applications, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Blood Gas Biochemistry Analyzer market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.